Editorial Board
Niketkumar Patel
QS Pharma · United States
Editorial leadership for Journal of Advanced Pharmaceutical Science And Technology ISSN 2328-0182
Research interests
- Topical
- Transdermal Delivery
- Iontophoretic Drug Delivery
- Formulation Of Liposomes
- Ethosomes
- Microemulsion
- And Solid Lipid Nanoparticles Oral Delivery: Dissolution Enhancement Techniques Including Particle Size Reduction
- Solid Dispersion
- Smedds
- Drug Nanoparticles
- Controlled Release
- Modified Release Oral Delivery Such As Tablets
- Microspheres. Disintergation
- Dissolution
- Design Of Experiments
- Quality By Design
- Pk Studies
- Iviv
Biography
- I have earned PhD in Pharmaceutics fron St. Johns' University and currently working as Formulation Scientist developing formulations for P-I/P-II/P-III clinical suppyl.
- Basic understanding of skin permeation and formulations for the transdermal delivery.
- Mentored the research work associated with formulation of Solid dispersions and SMEDS to improve dissolution rate of poorly soluble drug. Hands on experience and expertise in evaluation of the solubility/miscibility data, selection of excipients to avoid crystallization for final stable formulations, Ternary phase diagrams to select stable micro emulsions regions and also in vivo aspects of final fate of formulations.
- Assisted in the project involving oral delivery of Solid Lipid Nanoparticles (SLNs) for oral intestinal lymphatic delivery in order to avoid/reduce first pass metabolism.
- Knowledge and understanding of formulation and delivery aspects of Ethosomes, polymer based nanoparticles and drug nanoparticles (upstream/downstream) process as a part of other lab projects.
- In vivo permeation study of tacrine hydrochloride in SD rats and determination of pharmacokinetic parameters and PK analysis with WinNonlinÂ.
- Statistical evaluation of the data with Minitab and IVIVC study with Microsoft excel.
Considering JAPST for your work?
This journal is guided by Niketkumar Patel (QS Pharma) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.